-Healthcare Supply Chain Forum:Reboot and Rebuild- Taiwan-Israel COVID-19 Drug & Cell Therapy
2021-11-18 15:36:00

 

-Healthcare Supply Chain Forum:Reboot and Rebuild-
Taiwan-Israel COVID-19 Drug & Cell Therapy

Driven by COVID-19, the global healthcare supply chain has been undergoing drastic change towards onshoring manufacturing and building resilience. This forum invites Israeli and Taiwanese biopharmaceutical companies to shed light on outstanding achievements in COVID-19 drug development and breakthroughs in cell therapy, so as to inspire next steps taken from both sides for research, development, manufacturing or commercial partnerships.

15:00 (GMT+8);09:00 (GMT+2), Tuesday 23 November

Organiser:
Research Center for Biotechnology and Medicine Policy, Taiwan
Development Center for Biotechnology, Taiwan
Israel Advanced Technology Industries (IATI)

Agenda

Time (GMT+8)
Topic
Speaker
Video
15:00-15:05
Welcome Speech
Mr. Omer Caspi
Representative, Israel Economic and Cultural Office in Taipei
Time (GMT+8)
Topic
Speaker
Video
15:05-15:25
Welcome Speech
Karin Mayer Rubinstein, CEO & President, Israel Advanced Technology Industries (IATI)
Company Session
Time (GMT+8)
Topic
Speaker
Video
15:25-15:35
An oral revolution: between an oral insulin treatment and an oral COVID vaccine
Miriam Kidron, Chief Scientific Officer and Director of Oramed Pharmaceuticals. (Israel)
Time (GMT+8)
Topic
Speaker
Video
15:35-15:45
Placenta cell therapy to treat ARDS associated with Covid-19
Yaky Yanay, CEO & President, Pluristem Therapeutics (Israel)
Time (GMT+8)
Topic
Speaker
Video
15:45-15:55
Transforming Primary Care. Fulfilling the promise of Telehealth
Ofer Ben Zvi, Business Development Manager, Tyto Care
Time (GMT+8)
Topic
Speaker
Video
15:55-16:05
Umbilical Cord Blood Cell Therapy for Spinal Cord Injury
Tong-Young Lee, CEO, Stemcyte Taiwan Co., Ltd. (Taiwan)
Time (GMT+8)
Topic
Speaker
Video
16:05-16:15
Precision Medicine of Umbilical Cord Mesenchymal Stem Cells: COVID-19, Acute Myocardial Infarction, Stroke, and Cancer
Fei-Ting Hsu, Consultant, Ever Supreme Bio Technology Co., Ltd. (Taiwan)

 

© Institute for Biotechnology and Medicine Industry & Research Center for Biotechnology and Medicine Policy
Contact Us
Loading...